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ABSTRACT
Background Systematic reviews (SRs) are expected to
critically appraise included studies and privilege those at
lowest risk of bias (RoB) in the synthesis. This study
examines if and how critical appraisals inform the
synthesis and interpretation of evidence in SRs.
Methods All SRs published in March–May 2012 in 14
high-ranked medical journals and a sample from the
Cochrane library were systematically assessed by two
reviewers to determine if and how: critical appraisal was
conducted; RoB was summarised at study, domain and
review levels; and RoB appraisals informed the synthesis
process.
Results Of the 59 SRs studied, all except six (90%)
conducted a critical appraisal of the included studies, with
most using or adapting existing tools. Almost half of the SRs
reported critical appraisal in a manner that did not allow
readers to determine which studies included in a review
were most robust. RoB assessments were not incorporated
into synthesis in one-third (20) of the SRs, with their
consideration more likely when reviews focused on
randomised controlled trials. Common methods for
incorporating critical appraisals into the synthesis process
were sensitivity analysis, narrative discussion and exclusion of
studies at high RoB. Nearly half of the reviews which
investigated multiple outcomes and carried out study-level
RoB summaries did not consider the potential for RoB to
vary across outcomes.
Conclusions The conclusions of the SRs, published in
major journals, are frequently uninformed by the critical
appraisal process, even when conducted. This may be
particularly problematic for SRs of public health topics that
often draw on diverse study designs.
INTRODUCTION
Systematic reviews (SRs) are often considered a ‘gold
standard’ form of evidence and inform decision-
making across and beyond the health sciences.1–3 SRs
vary in methods and scope but frequently use a pre-
deﬁned comprehensive search strategy to identify all
potentially relevant studies; predeﬁned inclusion cri-
teria to minimise bias arising from the selective con-
sideration of evidence; and assess the risk of bias
(RoB) of included studies.2 4 Underpinning each
stage is a desire to reduce bias by prioritising evidence
from the most scientiﬁcally valid studies in a transpar-
ent and replicable way (see ﬁgure 1 for a conceptual
model summarising the conduct of SRs).
The term ‘study quality’ is widely used but remains
ill-deﬁned, and suggests investigating the extent to
which research is conducted to the highest possible
standards.4 This paper focuses on the narrower
concept of RoB, relating exclusively to internal valid-
ity. Studies with greater RoB often (but not always)
overestimate treatment effect sizes.5–7 The ﬁndings of
SRs that combine low RoB primary studies with
those at greater RoB may result in inappropriate
recommendations for practice or policy.2 4 8–10 To
prevent this, critical appraisal is recommended to
identify which ﬁndings should be emphasised as most
reliable.4 It aims to move synthesis beyond discre-
dited practices such as ‘cherry picking’, whereby ﬁnd-
ings that best ﬁt the reviewers’ own interests are
emphasised, and ‘vote counting’ in which the
reviewers prioritise ﬁndings that a majority of studies
agree on without considering whether those studies
are most robust. Critical appraisal allows reviewers to
explore whether contradictory ﬁndings between
studies reﬂect differing risks of bias, and so, for
example, help establish if ﬁndings from a minority of
included studies are more valid than the methodo-
logically weaker majority. They can also help
reviewers assess whether the overall evidence base for
a particular outcome is weak or strong. For example,
the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach to
assessing strength of review evidence considers crit-
ical appraisals when developing evidence-informed
recommendations.11 12
To ensure that SRs take account of RoB, it is not
enough to simply assess methodological character-
istics, nor even to describe those characteristics in a
table or text.4 13 Reviewers must use their critical
appraisals to inform subsequent review stages,
notably the synthesis and the conclusion-drawing
stages.
Numerous critical appraisal tools are avail-
able.4 14–16 Tools historically allowed summary
scores to be calculated for each randomised con-
trolled trial (RCT) included in an SR.17 A summary
score is a simple way of identifying high-quality
and low-quality studies and also an easy way to
incorporate into synthesis. However, some experts
view this approach as unsatisfactory since individ-
ual components of summary scores have been
found to discriminate between studies at high and
low RoB to a greater extent than overall
scores.18 19 Public health often draws upon diverse
forms of evidence that extend beyond RCTs,
making it even more challenging to identify which
studies have the lowest RoB.14 20 A further consid-
eration is that RoB may differ across outcomes
within the same study.6 For example, patient and
investigator blinding to outcome assessment may be
less important for all-cause mortality than for more
subjective measures like pain.
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Current Cochrane Collaboration guidance emphasises a move
away from rigid checklists and scores to an approach which
focuses on methodological ‘domains’ (such as allocation, blinding,
completeness of data) that should be tailored on the basis of the
review topic. This domain-level approach, which was developed
between 2005 and 2007, is intended to have some ﬂexibility and
involves subjective judgements made by reviewers regarding, for
example, the most appropriate domains to appraise, the relative
importance of each domain, and the overall RoB, both within and
across studies.4 21 These judgements should be outcome-speciﬁc
and ideally informed by empirical evidence of bias, the likely dir-
ection of bias and the likely magnitude of bias. However, this may
be difﬁcult to achieve in practice, given the acknowledged evi-
dence gap in the relative importance of different domains of bias.4
Incorporation of RoB assessments into synthesis is crucial to
ensure that SR conclusions are based on the best available evi-
dence. Failure has serious implications for evidence-informed
policy and practice. In this study, we explore if and how critical
appraisals inform the synthesis and interpretation of evidence in
recent SRs published in high-impact journals and in the
Cochrane database.
METHODS
SRs published in 14 journals, between March 2012 and May
2012 inclusive, were identiﬁed by manual searches carried out
independently by two reviewers (SVK and ME). These journals
were purposively chosen to provide coverage of highly ranked
journals within the ﬁelds of general medicine, general practice,
Figure 1 Conceptual model outlining factors to consider when undertaking a systematic review. GRADE, Grading of Recommendations
Assessment, Development and Evaluation.
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paediatrics and public health (see web appendix or table 1 for
list of journals). To be included in the study, the reviews had to
be published in journal issues during this period (and not in
online ﬁrst format only) and self-deﬁned by the authors as SRs.
The ﬁrst ﬁve new Cochrane SRs published in each of these
months were also considered, as Cochrane SRs have been
reported as being conducted to a higher methodological quality
than those published elsewhere.22 23 When SRs do not attempt
to synthesise ﬁndings across studies (eg, those conducted to
study review methodology), assessments of RoB do not usually
inform the synthesis process and were therefore excluded.
Additional details were retrieved if provided in appendices and
published protocols, or cited in separate documents.
A standard data extraction template was created in Microsoft
Excel 2007 based on guidelines produced by the Cochrane
Collaboration4 (see online appendix). These included details
about the study characteristics, the critical appraisal process, the
evidence synthesis approach taken and how critical appraisal
informed the ﬁndings presented in the SR. Data extraction
included abstractions based on predeﬁned categories as well as
qualitative text data (to allow a combination of systematic assess-
ment and depth to be achieved). Both reviewers carried out data
extraction independently, with disagreements resolved by con-
sensus and discussion with a third author (MP).
The categories for coding data extraction were as follows:
Studies were grouped by topics into ‘healthcare intervention’
(intervention delivery within a health services setting); ‘other
health intervention’ (intervention study but delivered in a
non-health services setting); ‘observational epidemiology’ and
‘qualitative’ study. The type of critical appraisal tool was cate-
gorised under: ‘standard tool’ when authors used a previously
published tool (eg, Cochrane risk of bias tool, Hamilton tool)
without modiﬁcation; ‘adapted tool’ when a previously pub-
lished tool was modiﬁed by the authors for their review
purpose; ‘bespoke tool’ when a new tool was created by the
authors; ‘description’ when information from included studies
was extracted but not related to RoB (including data extraction
using reporting guidelines, such as the STROBE statement); and
‘none’ when no information relevant to RoB was extracted.
Further information collected about critical appraisal included
whether a separate appraisal was conducted for each outcome
and if the individual criteria used in the critical appraisal were
reported. Where further information on the critical appraisal
tool was provided in a protocol or citation, the original material
was retrieved.
We determined if the reviews allowed readers to rank studies
by RoB, and for those that did, how: use of a ‘summary score’
(where the number of RoB criteria were added together);
‘threshold summary score’ (where a summary score was deemed
low RoB, if achieving a cut-off score); ‘weighted score’ (where
criteria are added together, with some factors given greater
weighting); ‘speciﬁc domains prioritised’ (when some RoB
domains were considered most important but without utilising a
numeric score); ‘all criteria required’ (when all of the appraisal
criteria needed to be met for the study to be deemed low RoB);
‘unclear’ (when it was difﬁcult to determine the process by
which authors differentiated studies by their RoB). Information
on whether RoB assessments were incorporated was assessed by
reviewing all available published information, with even
minimal evidence for incorporation acceptable. In addition,
how incorporation of RoB was achieved in the synthesis (sensi-
tivity analysis, narrative discussion, exclusion of studies at high
RoB and ‘other’) was also extracted. Lastly, the levels at which
RoB was summarised in reviews was noted. This included
determining whether RoB was assessed at the domain level
within studies included in a review, at the study level, across
studies, and at the review level (including how).
RESULTS
A total of 59 SRs that met the inclusion criteria were identiﬁed
(table 1). Considerable diversity was achieved in the sample of
SRs, with reviews considering a broad range of research ques-
tions and synthesising a wide variety of types of evidence
(see web appendix table 1 for further details of each included
review). Most reviews were either focused on evaluating health-
care interventions (42%) or observational epidemiology (37%)
with other types of health intervention (such as preventive inter-
ventions or clinical management tools) and qualitative reviews
comprising a minority.
All except 6 (10%) of the reviews conducted critical appraisal
as part of the review process (table 2). In most cases, this
involved the use or adaptation of an existing critical appraisal
tool. However, two studies used guidelines for study reporting
(such as STROBE24) rather than tools for appraising RoB. Of
the 42 studies that investigated multiple outcomes through a
critical appraisal, 15 did not carry out separate critical appraisals
for each outcome.
Twenty eight (54%) of the SRs ranked studies by RoB, or at
least provided sufﬁcient information to enable readers to differ-
entiate between which studies were at higher RoB and which
studies were at lower RoB. Of these, eight reviews used an
approach based on summary scores of criteria to identify those
studies at the lowest RoB (table 3). In ﬁve cases, all criteria were
required for a study to be considered at low RoB and only a
Table 1 Characteristics of systematic reviews included in analysis
Number of
reviews
% of category
total
Topic of systematic review
Healthcare intervention 25 42
Other health intervention 9 15
Observational epidemiology 22 37
Qualitative 3 5
Journal
Addiction 2 3
American Journal of Public
Health
2 3
Annals of Family Medicine 3 5
Annals of Internal Medicine 8 14
BMJ 8 14
British Journal of General
Practice
2 3
Cochrane Database 14 24
JAMA 3 5
Lancet 3 5
Pediatrics 6 10
PLoS Medicine 3 5
Preventive Medicine 1 2
Social Science and Medicine 4 7
Number of outcomes
Single 11 19
Multiple 48 81
Summative synthesis
Meta-analysis 44 75
No meta-analysis 15 25
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further ﬁve SRs adopted the Cochrane Handbook’s approach of
prioritising speciﬁc domains to determine which studies had the
lowest RoB. Of the four Cochrane reviews to allow included
studies to be ranked by RoB, three explained which domain
assessments formed the basis for prioritisation. However, none
of the reviews, including the Cochrane reviews, provided a justi-
ﬁcation for why these domains had been prioritised; and in six
reviews, it was unclear on what basis the studies had been iden-
tiﬁed as being at a high or low RoB.
In 20 reviews, critical appraisal did not explicitly inform
the synthesis stage, and therefore did not appear to inﬂuence
the review ﬁndings (table 4). SRs that only included RCTs to
study intervention effectiveness more commonly incorporated
RoB (17 of 24, 71%), compared to reviews that included
RCTs alongside other designs (8 of 12, 67%) and those that
only included other designs (10 of 23, 57%). For reviews that
made use of RoB assessments, these were most commonly
incorporated into the synthesis process, either narratively or
through sensitivity analysis. Of the six Cochrane reviews that
planned to carry out sensitivity analysis, half of them were
unable to do so due to the small number of included studies,
with the result that two reviews of RCTs appeared to neglect
quality in the synthesis process. A small number of studies
(n=6) incorporated RoB assessments into synthesis using mul-
tiple approaches. These assessments were used in a variety of
other ways, as shown in table 4 and the web appendix. When
RoB was not incorporated into synthesis, examples of vote
counting were found,25–27 even though the study methods
had been assessed.
SRs assessing multiple outcomes frequently (n=12) sum-
marised RoB at the study level across outcomes, thereby assign-
ing the same RoB assessment to a study irrespective of the
potential for bias for each outcome (table 5). One-third of the
studies summarised bias at the review level. In most cases, these
review-level summaries of bias used standardised approaches
such as the GRADE guidelines.
DISCUSSION
Although critical appraisals of the included studies are fre-
quently conducted in SRs published in major journals, the con-
clusions of those reviews are frequently uninformed by this
process. SRs that focus on study designs other than RCTs may
be particularly subject to this problem. There have been
instances of reviewers not carrying out critical appraisals.
Assessing RoB using scoring systems continues, despite the
Cochrane Collaboration’s recommendations to avoid their use.
Table 2 Details regarding critical appraisal used in systematic
reviews
Numbers of
reviews
% of category
total
Critical appraisal
Standard tool (pre-existing tool used
without modification)
37 63
Adapted tool (pre-existing tool
adapted for review)
10 17
Bespoke tool (new tool created by
authors)
4 7
Description (reporting of study
characteristics only)
2 3
Other 0 0
None 6 10
Separate appraisal per outcome
Yes 27 52
No 15 29
N/A (single outcome review) 10 19
Domain-level assessments of risk of bias (eg, outcomes blinded, selective
outcome data)
Domain-level risk of bias presented 25 48
Individual criteria grouped into
domains presented
5 10
No domain summary for risk of bias 22 42
Individual appraisal criteria reported
Yes 26 50
No 26 50
Critical appraisal allows ranking of studies
Yes 28 54
No 24 46
Table 3 Methods for ranking included studies by risk of bias in
systematic reviews
Numbers of
reviews
% of
category
total
Simple summary score (criteria met added
together)
4 14
Cut-off threshold score (summary score
dichotomised on the basis of a cut-off )
4 14
Weighted score (criteria added together,
with some factors given greater weighting as
deemed more important)
1 4
Specific domains prioritised (some risk of
bias domains, such as allocation
concealment or blinding, deemed more
important)
5 18
All criteria required 5 18
Unclear 6 21
Only one criterion difference between
included studies
1 4
Combination of score and domain
prioritisation
2 7
Table 4 Methods for Incorporating risk of bias assessments into
reviews during synthesis
Number of
reviews
% of category
total
Were risk of bias assessments incorporated into synthesis?
Yes 37 63
No 20 34
Not applicable 2 3
How were risk of bias assessments incorporated into synthesis?*
Sensitivity analysis (eg, limiting to studies
at lowest risk of bias in a secondary
analysis)
20 54
Narrative (discussion within text) 14 38
Exclusion of studies at high risk of bias
from main review synthesis
5 14
Other approach 4 11
*Denominator is the number of reviews that incorporated risk of bias into the
synthesis process. Note that the total adds up to more than 100% because some
reviews used multiple methods. The list of other approaches used is available in the
web appendix.
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More strikingly, the practice of carrying out a critical appraisal
which does not subsequently inform ﬁndings of the synthesis
process appears common. This resulted in some reviews engaging
in ‘vote counting’, where the number of studies is counted to
provide an indication of the strength of evidence. Ignoring critical
appraisal in this way may result in policy and practice recommen-
dations not based on the best available evidence, thereby threa-
tening the validity of the SR process. Approaches to
incorporating RoB assessments into the ﬁndings of SRs are (argu-
ably appropriately) varied but frequently lack transparency. Lastly,
some SRs that investigate multiple outcomes continue to ignore
the potential for RoB to differ across outcomes.
Our study has a number of strengths. We adopted a structured
approach to investigate SR practices, making use of two inde-
pendent reviewers. Our methods allowed detailed investigations
of how RoB is assessed and then incorporated the assessments
into the ﬁndings of SRs. However, some limitations are note-
worthy. First, the SRs examined are not a random sample of all
works that had been published. Instead, we assessed SR practice
by analysing reviews published in high-quality journals across a
number of areas of health research. Our study therefore high-
lights the existence of problematic practices, but most likely
underestimates their frequency. Similarly, we have not analysed a
sample large enough to provide accurate statistical estimates of
the frequency of these practices but instead sought in-depth data
obtained from a more qualitative approach. This has allowed us
to present a diversity of approaches that are currently being
used. Our study is based on a sample of published material only
and some practices may not be evident. For example, reviewers
not reporting numerically summarised RoB scores may have
nevertheless informally calculated them to assist with synthesis.
Lastly, the Cochrane guidelines are regularly revised to
incorporate developments in best practice and new research.21
Therefore, it may be inappropriate to expect all Cochrane
reviews to incorporate the latest guidance. However, our ﬁnd-
ings show that many Cochrane SRs selectively followed some
but not all of the recently published guidance.
Much of the previous literature focused on limitations of crit-
ical appraisal tools,15 28 29 particularly for observational
studies,14 rather than how RoB assessments are subsequently
incorporated into SR ﬁndings. Moja et al13 found that SRs pub-
lished in 1995–2002 frequently ignored critical appraisals
during synthesis, but at the time noted that the methods for
assessing and incorporating RoB assessments were in their
infancy. Similarly, de Craen et al30 investigated how SRs of
RCTs published in 2002–2003 incorporated RoB assessments
into their synthesis. Half of the reviews published in the sample
from the Cochrane library and leading general medical journals
did not incorporate ﬁndings of critical appraisal into their
review. Most recently, Hopewell et al31 reported a lack of RoB
incorporation into synthesis and meta-analysis within Cochrane
and non-Cochrane SRs of RCTs, with the latter performing
more poorly. Although there is evidence that many aspects of
SR conduct are improving,23 our research demonstrates that
problems with the utilisation of critical appraisal in synthesis
still persist. Importantly, we document the relevance of this
issue for diverse forms of evidence beyond RCTs. By comparing
SRs that include RCTs with SRs of observational studies, our
ﬁndings highlight the particular need for further research on the
latter.
Over the past decade, considerable progress has been made in
developing guidelines for conducting SRs4 32 and developing
clinical and public health guidelines.11 However, these develop-
ments have made the SR process more complicated. Concerns
over using RoB summary scores resulted in the Cochrane guide-
lines arguing for a move away from standardised scoring
systems, which combined ease of use with transparency. Our
ﬁndings not only show that RoB summary scores are still
frequently used but also suggest that there is confusion about
how best to incorporate critical appraisals into SR ﬁndings. This
resulted in critical appraisals being ignored, despite having been
conducted. Even when appraisals inform SR ﬁndings, it is fre-
quently unclear as to how they have been used and the reasons
for privileging some studies over others. This lack of clarity
threatens the transparency and reproducibility of SRs.
While it is not always appropriate to carry out an SR that
meets all the requirements of a Cochrane review,33 considering
RoB remains important for all reviewers. An overarching prin-
ciple that may be helpful to remember when conducting synthe-
sis in SRs is to consider what the best available evidence
recommends, which may not necessarily reﬂect the overall
evidence base.20 At a minimum, this suggests that reviewers
should clearly report ﬁndings from the most robust studies,
either as a sensitivity analysis or in the primary analysis.
Depending on the studies being reviewed, statistical and/or nar-
rative techniques may be appropriate. Given that the study
design and type of intervention are closely related, reviewers
should ideally go further and consider whether an ‘intervention
selection bias’ is inadvertently introduced by focusing only on
higher quality studies. This means it may be helpful to examine
whether the types of interventions evaluated in higher RoB
studies differ systematically from lower RoB studies, for
example, the latter may focus on individual-level interventions
evaluated using RCTs while higher RoB studies may be more
likely to include observational evaluations of population-level
interventions (eg, public policies).20 34
Table 5 Summaries of risk of bias conducted by systematic
reviews
Number of
reviews
% of
category
total
Was a summary of risk of bias presented at the study level?
No risk of bias assessment at the study
level
26 45
Review studying a single outcome which
presents risk of bias at the study level
7 12
Review studying multiple outcomes which
summarise the risk of bias at the study
level but does not assess the risk of bias
separately for each outcome
12 21
Review studying multiple outcomes which
summarise the risk of bias separately for
each outcome
13 22
Was a summary of the risk of bias presented for each outcome across studies?
Yes 30 52
No 28 48
Was a review-level summary risk of bias provided?
Yes 19 33
No 39 67
How was the risk of bias summarised at the review level?*
GRADE 11 58
Cochrane risk of bias table 7 37
Narrative statement (in text) 4 21
*Denominator is the number of reviews providing a review-level summary risk of bias.
Note that the total adds up to more than 100% because some reviews used multiple
methods for summarising bias at the review level.
GRADE, Grading of Recommendations Assessment, Development and Evaluation.
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Early tools for critical appraisal were appealing because they
were simple to use and resulted in a score which allowed
ranking of studies by RoB, facilitating incorporation into the
synthesis process.17 19 35 Unfortunately, this simplicity came to
be regarded as a source of weakness, as well as a strength, and
these tools have been replaced by more complex guidance
intended to address some of their limitations.4 21 36 We recog-
nise the need for this development but take the view, supported
we believe by this study, that reviewers are struggling to under-
stand and/or operationalise current guidance on how to conduct
and incorporate critical appraisal within synthesis. Further
research is required to establish the relative importance of differ-
ent forms of bias and their likely impact6 37 and also to clarify
how critical appraisals should be incorporated into SR
ﬁndings.38 39 However, to ensure that SRs really do direct
decision-makers to the best available evidence, there is an
urgent need to make guidance more understandable to the
diverse reviewers involved.
What is already known?
▸ Systematic reviews are a key mechanism for facilitating
evidence-informed decision-making and commonly draw
upon diverse study designs.
▸ Critical appraisal is necessary to identify which studies have
the lowest risk of bias and is now more consistently
conducted within systematic reviews.
What does this study add?
▸ Even when critical appraisal is carried out, it often does not
inform the evidence synthesis process, particularly for
systematic reviews of non-randomised studies.
▸ Common methods for incorporating risk of bias assessments
into the synthesis process include sensitivity analysis,
narrative assessment and restricting the synthesis to studies
at a lower risk of bias.
▸ There is an urgent need for greater clarity in systematic
review guidance and understanding among authors that the
critical appraisal process must inform the ﬁnal synthesis; so
systematic reviews are based on the best available evidence.
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